Bone Biologics Corp (BBLGW) Accumulated Expenses (2010 - 2021)
Bone Biologics (BBLGW) posted quarterly Accumulated Expenses of $297500.0 for Q4 2021, up 17.82% year-over-year from $252500.0 in Q4 2020, and down 85.43% quarter-over-quarter from $2.0 million in Q3 2021.
Bone Biologics Corp (BBLGW) Accumulated Expenses (2010 - 2021) Analysis & Trends
Bone Biologics (BBLGW) has reported Accumulated Expenses for 12 consecutive years, with $297500.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Accumulated Expenses rose 17.82% year-over-year to $297500.0; the TTM figure through Dec 2021 stood at $297500.0 (up 17.82% YoY), while the FY2021 annual figure was $297500.0, up 17.82% from the prior year.
- Accumulated Expenses slipped to $297500.0 in Q4 2021 per BBLGW's latest filing, from $2.0 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.0 million in Q3 2021 and bottomed at $62225.0 in Q2 2018.
- Historically, Accumulated Expenses has averaged $435574.0 across 5 years, with a median of $253025.5 in 2019.
- Annual changes were most pronounced in 2017 — Accumulated Expenses surged 10073.92% — and 2018, when it plunged 84.21%.
- Bone Biologics' Accumulated Expenses stood at $456000.0 in 2017, then slumped by 84.21% to $72017.0 in 2018, then surged by 252.07% to $253551.0 in 2019, then retreated by 0.41% to $252500.0 in 2020, then grew by 17.82% to $297500.0 in 2021.
- Business Quant data shows BBLGW's Accumulated Expenses at $297500.0 in Q4 2021, $2.0 million in Q3 2021, and $1.8 million in Q2 2021.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 297,500.00 |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Mar 31, 2021 | 267,500.00 |
| Dec 31, 2020 | 252,500.00 |
| Sep 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 93,892.00 |
| Mar 31, 2020 | 207,500.00 |
| Dec 31, 2019 | 253,551.00 |
| Sep 30, 2019 | 177,500.00 |
| Jun 30, 2019 | 162,500.00 |
| Mar 31, 2019 | 491,667.00 |
| Dec 31, 2018 | 72,017.00 |
| Sep 30, 2018 | 391,667.00 |
| Jun 30, 2018 | 62,225.00 |
| Mar 31, 2018 | 291,667.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 191,667.00 |
| Jun 30, 2017 | 141,667.00 |
| Mar 31, 2017 | 91,667.00 |